Novel plasma proteomic biomarkers for early identification of induction chemotherapy beneficiaries in locoregionally advanced nasopharyngeal carcinoma

HIGHLIGHTS

  • who: Shan-Qiang Zhang and collaborators from the Capital Medical University, China have published the Article: Novel Plasma Proteomic Biomarkers for Early Identification of Induction Chemotherapy Beneficiaries in Locoregionally Advanced Nasopharyngeal Carcinoma, in the Journal: (JOURNAL)
  • what: The four candidate biomarkers identified in this study have been linked to physiological processes or chemotherapy resistance related to malignant diseases .
  • future: In addition to methods such as enzyme-linked immunosorbent assays considering that IC usually involves two or more drugs which are administered to the patients at the same time functional study of the potential . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?